PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Plastic Surgery, University Toulouse III Paul Sabatier, Toulouse, France; Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: elupon@mgh.harvard.edu.\', \'Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Department of Plastic Surgery, European George Pompidou Hospital, University of Paris, Paris, France. Electronic address: alellouch@mgh.harvard.edu.\', \'Department HEMARINA S.A., Aéropole centre, Biotechnopôle, Morlaix, France. Electronic address: franck.zal@hemarina.com.\', \'Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Department of Plastic Surgery, Massachusetts General Hospital, Boston, MA, United States. Electronic address: CCETRULO@mgh.harvard.edu.\', \'Department of Plastic Surgery, European George Pompidou Hospital, University of Paris, Paris, France. Electronic address: laurentlantieri@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)33312-010.1016/j.mehy.2020.110421
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 33308935
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO2Life® (M101).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all